Xaira Therapeutics
Integrated biotechnology company focusing on leveraging artificial intelligence to transform drug discovery and development.
Launch date
Employees
Market cap
-
Enterprise valuation
$4.0—6.0b (Dealroom.co estimates Apr 2024.)
San Francisco California (HQ)
Authorizing premium user...